TSE:CRON

Cronos Group Stock Forecast, Price & News

C$10.43
+0.26 (+2.56 %)
(As of 04/16/2021 12:00 AM ET)
Add
Compare
Today's Range
C$9.94
Now: C$10.43
C$10.48
50-Day Range
C$10.17
MA: C$12.10
C$13.97
52-Week Range
C$6.54
Now: C$10.43
C$20.08
Volume338,338 shs
Average Volume998,247 shs
Market CapitalizationC$3.76 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Cronos Group Inc. operates as a cannabinoid company in the United States and internationally. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through ecommerce, retail, and hospitality partner channels. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. Its brand portfolio includes PEACE NATURALS, a global wellness platform; adult-use brands comprise COVE and Spinach; and hemp-derived CBD brands consists of Lord Jones and PEACE+. Cronos Group Inc. is based in Toronto, Canada.
Cronos Group logo

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone416-504-0004
Employees631
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$46.72 million
Cash FlowC$3.67 per share
Book ValueC$4.75 per share

Profitability

Miscellaneous

Market CapC$3.76 billion
Next Earnings DateN/A
OptionableOptionable

Headlines

Stocks Take Breather from Records
April 12, 2021 |  ca.finance.yahoo.com
Cronos Group Enters Oversold Territory (CRON)
April 12, 2021 |  nasdaq.com
7 Great Stocks to Buy Under $10
April 8, 2021 |  investorplace.com
CRON May 28th Options Begin Trading
April 8, 2021 |  nasdaq.com
Cronos Group (TSE:CRON) Stock Price Down 1.2%
March 30, 2021 |  americanbankingnews.com
Indexes Retreat, Weighed by Health-Care
March 23, 2021 |  baystreet.ca
First Week of CRON May 21st Options Trading
March 19, 2021 |  nasdaq.com
Company News for Mar 1, 2021
March 1, 2021 |  finance.yahoo.com
Canadian Market Holds In Positive Territory As Healthcare Stocks Rebound
February 19, 2021 |  markets.businessinsider.com
TSX Records Fresh Closing High As Healthcare, Energy Stocks Rally
February 10, 2021 |  markets.businessinsider.com
See More Headlines

MarketRank

Overall MarketRank

0.69 out of 5 stars

Analyst Opinion: 1.3Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
C$10.43
+0.26 (+2.56 %)
(As of 04/16/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CRON News and Ratings via Email

Sign-up to receive the latest news and ratings for CRON and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Cronos Group (TSE:CRON) Frequently Asked Questions

Is Cronos Group a buy right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Cronos Group stock.
View analyst ratings for Cronos Group
or view top-rated stocks.

What stocks does MarketBeat like better than Cronos Group?

Wall Street analysts have given Cronos Group a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Cronos Group wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has Cronos Group's stock price been impacted by Coronavirus (COVID-19)?

Cronos Group's stock was trading at C$7.45 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CRON stock has increased by 40.0% and is now trading at C$10.43.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for CRON?

3 Wall Street analysts have issued 1 year price objectives for Cronos Group's stock. Their forecasts range from C$5.90 to C$14.00. On average, they anticipate Cronos Group's share price to reach C$9.68 in the next year. This suggests that the stock has a possible downside of 7.2%.
View analysts' price targets for Cronos Group
or view top-rated stocks among Wall Street analysts.

Who are Cronos Group's key executives?

Cronos Group's management team includes the following people:
  • Mr. Michael Ryan Gorenstein, Exec. Chairman (Age 34, Pay $333.57k)
  • Mr. Jerry Filomena Barbato, Chief Financial Officer (Age 45, Pay $299.63k)
  • Ms. Xiuming Shum, Exec. VP of Legal and Regulatory Affairs & Corp. Sec. (Age 35, Pay $190.18k)
  • Mr. Kurt Thomas Schmidt B.Sc., M.B.A., Pres & CEO (Age 64)
  • Mr. Shayne J. Laidlaw, Director of Investor Relations & Strategy
  • Ms. Shannon Buggy, Sr. VP & Global Head of People
  • Ms. Anna Shlimak, Sr. VP of Corp. Affairs (Age 35)
  • Dr. Todd K. Abraham, Chief Innovation Officer (Age 66)
  • Puneet Mathur, VP & Controller
  • Ms. Summer Frein, Gen. Mang. of USA (Age 37)

Who are some of Cronos Group's key competitors?

What other stocks do shareholders of Cronos Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include Aurora Cannabis (ACB), (CGC), Aurora Cannabis (ACB), Canopy Growth (WEED), NVIDIA (NVDA), Aphria (APHA), Advanced Micro Devices (AMD), Netflix (NFLX), The Walt Disney (DIS) and Intel (INTC).

What is Cronos Group's stock symbol?

Cronos Group trades on the Toronto Stock Exchange (TSX) under the ticker symbol "CRON."

How do I buy shares of Cronos Group?

Shares of CRON and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Cronos Group's stock price today?

One share of CRON stock can currently be purchased for approximately C$10.43.

How much money does Cronos Group make?

Cronos Group has a market capitalization of C$3.76 billion and generates C$46.72 million in revenue each year.

How many employees does Cronos Group have?

Cronos Group employs 631 workers across the globe.

What is Cronos Group's official website?

The official website for Cronos Group is www.thecronosgroup.com.

How can I contact Cronos Group?

The company can be reached via phone at 416-504-0004.


This page was last updated on 4/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.